SD BioSensor, Inc
KRX:137310.KS
9780 (KRW) • At close September 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) KRW.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Revenue
| 655,676.513 | 2,932,001.44 | 2,929,960.84 | 1,686,163.033 | 72,962.238 | 65,633.389 |
| Cost of Revenue
| 626,469.474 | 1,539,006.778 | 1,359,930.199 | 828,000.792 | 52,152.114 | 45,595.639 |
| Gross Profit
| 29,207.039 | 1,392,994.662 | 1,570,030.641 | 858,162.241 | 20,810.124 | 20,037.75 |
| Gross Profit Ratio
| 0.045 | 0.475 | 0.536 | 0.509 | 0.285 | 0.305 |
| Reseach & Development Expenses
| 60,059.974 | 45,762.481 | 18,885.658 | 10,387.58 | 4,869.391 | 4,265.918 |
| General & Administrative Expenses
| 22,955.324 | 12,608.286 | 4,707.117 | 1,947.12 | 1,632.233 | 0 |
| Selling & Marketing Expenses
| 88,121.909 | 75,686.791 | 123,982.968 | 79,979.015 | 4,540.288 | 0 |
| SG&A
| 206,363.039 | 88,295.077 | 128,690.085 | 81,926.135 | 6,172.521 | 12,456.537 |
| Other Expenses
| -10,868.596 | 112,312.708 | 58,414.319 | 27,584.027 | 8,248.509 | -275.543 |
| Operating Expenses
| 277,291.609 | 246,370.266 | 205,990.062 | 119,897.742 | 19,290.421 | 16,997.998 |
| Operating Income
| -248,084.57 | 1,146,624.395 | 1,364,040.579 | 738,264.499 | 1,519.703 | 3,039.753 |
| Operating Income Ratio
| -0.378 | 0.391 | 0.466 | 0.438 | 0.021 | 0.046 |
| Total Other Income Expenses Net
| -189,542.496 | 95,464.074 | 76,776.516 | -21,027.353 | 682.754 | 783.153 |
| Income Before Tax
| -437,627.065 | 1,242,088.47 | 1,440,817.095 | 717,237.147 | 2,202.457 | 3,822.906 |
| Income Before Tax Ratio
| -0.667 | 0.424 | 0.492 | 0.425 | 0.03 | 0.058 |
| Income Tax Expense
| 29,290.121 | 333,299.788 | 376,384.935 | 95,623.288 | -928.644 | -142.106 |
| Net Income
| -467,711.537 | 911,362.364 | 1,088,470.714 | 615,635.989 | 3,153.182 | 3,031.674 |
| Net Income Ratio
| -0.713 | 0.311 | 0.371 | 0.365 | 0.043 | 0.046 |
| EPS
| -4,218.95 | 8,996.76 | 11,161 | 5,990.92 | 30.68 | 29.5 |
| EPS Diluted
| -4,218.95 | 8,996.76 | 11,161 | 5,990.92 | 30.68 | 29.5 |
| EBITDA
| -110,543.368 | 1,301,038.192 | 1,455,440.631 | 726,705.048 | 5,746.243 | 7,444.706 |
| EBITDA Ratio
| -0.169 | 0.444 | 0.497 | 0.431 | 0.079 | 0.113 |